AR and prostate cancer: Conversely, in vivo tissue recombination models with primary prostate cancer cells combined with either AR-positive or AR-negative prostate myofibroblasts have shown that low stromal AR decreases castration-induced apoptosis and may impair invasion by maintaining an ECM microenvironment that suppresses cell movement [263].